Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 12.10.2026 1 AJNR Am J Neuroradiol 1 Ann Neurol 4 Br J Cancer 2 Br J Neurosurg 1 Cancer 2 Cancer Res 1 Childs Nerv Syst 1 J Natl Cancer Inst 8 J Neurooncol 2 J Neurosurg 9 Neuro Oncol 1 Neurology 1 Neuroradiology 1 Neurosurgery 1 Radiol Artif Intell

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. ALLAEI A, Cortes Magdaleno HA, Amadeo E, Marole KK, et al
   Intratumoral susceptibility signals on susceptibility-weighted imaging for glioma grading and molecular profiling: a systematic review and meta-analysis.
   AJNR Am J Neuroradiol. 2026 Oct 9:ajnr.A9672. doi: 10.3174/ajnr.A9672.
   PubMed         Abstract available
   
   

   
   Ann Neurol

2. ABOSEIF A, Cacciaguerra L, Vilaseca A, Kondrakunta S, et al
   Selective Limbic and Striatal Atrophy Corresponds to Regional Gene Expression in Leucine-Rich Glioma-Inactivated-1 Immunoglobulin G Autoimmune Encephalitis.
   Ann Neurol. 2026 Oct 6. doi: 10.1002/ana.78389.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. WANG Z, Sun Q, Li C, Sun T, et al
   LAIR1 suppresses phagocytosis via SHP2/USP22-mediated MYH9 degradation in glioma-associated microglia/macrophages to drive immunosuppression.
   Br J Cancer. 2026 Oct 8. doi: 10.1038/s41416-026-03617.
   PubMed         Abstract available
   
   
4. OKAMOTO T, Mizuta R, Demachi-Okamura A, Muraoka D, et al
   Abundant CD8(+) tumor-infiltrating lymphocytes in glioblastoma harbor distinct exhaustion signatures in potentially reactive subsets.
   Br J Cancer. 2026 Oct 5. doi: 10.1038/s41416-026-03619.
   PubMed         Abstract available
   
   
5. SHI C, Ren L, Sun C, Yu L, et al
   Retraction Note: miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
   Br J Cancer. 2026 Oct 2. doi: 10.1038/s41416-026-03643.
   PubMed        
   
   
6. ADAMSKI J, Apps JR, Depani S, Hill RM, et al
   Strategic roadmap for delivery of clinical trials in rare childhood central nervous system (CNS) tumours: a multi-stakeholder consensus.
   Br J Cancer. 2026;135:1183-1193.
   PubMed         Abstract available
   
   

   
   Br J Neurosurg

7. DABLOUK MO, Buckley K, Faul S, O'Sullivan MGJ, et al
   Intraoperative fluorescence spectroscopy for IDH classification in glioma: a feasibility study.
   Br J Neurosurg. 2026 Oct 9:1-7. doi: 10.1080/02688697.2026.2746372.
   PubMed         Abstract available
   
   
8. DORBY HA, Stan A, Suttner N
   Acute ring-enhancing change in a previously solidly enhancing meningioma.
   Br J Neurosurg. 2026 Oct 7:1-6. doi: 10.1080/02688697.2026.2743541.
   PubMed         Abstract available
   
   

   
   Cancer

9. CANASLAN K, Pan K, Leal T
   Redefining leptomeningeal metastasis in non-small cell lung cancer: From terminal complication to molecularly managed disease.
   Cancer. 2026;132:e70624.
   PubMed         Abstract available
   
   

   
   Cancer Res

10. LIU Z, Lin J, Chen T, Zhang W, et al
    Targeting SLC38A5 Overcomes alphaPD-1 Immunotherapy Resistance by Alleviating Glutamine Competition Between Glioblastoma Cells and T Cells.
    Cancer Res. 2026 Oct 5. doi: 10.1158/0008-5472.CAN-26-0774.
    PubMed         Abstract available
    
    
11. MALLA AP, Flick M, Fang JR, Fan X, et al
    Longitudinal Surgical Modeling of Early Glioblastoma Recurrence Reveals Emergence of Margin-Associated Neural Programs.
    Cancer Res. 2026 Oct 5. doi: 10.1158/0008-5472.CAN-25-5176.
    PubMed         Abstract available
    
    

    
    Childs Nerv Syst

12. DAMODHARAN S
    Timing of radiotherapy and autologous stem cell transplantation in embryonal tumor with multilayered rosettes: a critical narrative review.
    Childs Nerv Syst. 2026;42:387.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

13. RAGHAVENDRA AS, Kotecki N, Jennings K, Amato O, et al
    A validated clinical calculator of a brain metastasis risk (BrMR) prediction model in stage I-III breast cancer patients.
    J Natl Cancer Inst. 2026 Oct 8:djag377. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurooncol

14. PRICE AM, Fredricks NS, Koutsouras G, Vallejo FA, et al
    Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments).
    J Neurooncol. 2026;180:6.
    PubMed         Abstract available
    
    
15. KOKETSU Y, Hasegawa T, Kato T, Naito T, et al
    Dose selection and clinical decision-making after Gamma Knife surgery for large brain metastases: implications for early identification of true progression.
    J Neurooncol. 2026;180:3.
    PubMed         Abstract available
    
    
16. PARK J, Buclez P, Lubisich J, Hanubal K, et al
    Predictive modeling of lung cancer subtype with integration of clinical and thoracic imaging features to guide early brain metastasis management.
    J Neurooncol. 2026;180:5.
    PubMed         Abstract available
    
    
17. KALLURI AL, Carmichael A, Rakovec M, Jiang K, et al
    Surgical characteristics and postoperative outcomes in a retrospective cohort study of patients with molecularly defined oligodendroglioma.
    J Neurooncol. 2026;180:4.
    PubMed         Abstract available
    
    
18. RAJKUMAR S, Moy H, Ji X, Aboian M, et al
    Volumetric analysis of radiographic changes after stereotactic radiosurgery for treatment of non-responding brain metastases.
    J Neurooncol. 2026;180:7.
    PubMed         Abstract available
    
    
19. VALLEJO FA, Monsour MA, Fredricks NS, Tsang DS, et al
    Supratentorial ependymoma: a comprehensive review of molecular classification, management strategies, and clinical outcomes (Part II of pediatric ependymomas across compartments).
    J Neurooncol. 2026;180:8.
    PubMed         Abstract available
    
    
20. EIBL T, Mercea PA, Liebert A, Ritter L, et al
    Risk stratification for unfavorable outcome after resection of selected brain metastases in patients with multiple brain metastases.
    J Neurooncol. 2026;180:9.
    PubMed         Abstract available
    
    
21. LI B, Liang R, Altawalbeh G, Hoenikl L, et al
    Longitudinal spatial changes of the contralesional corticospinal tract in high-grade glioma: a within-patient DTI tractography study.
    J Neurooncol. 2026;180:10.
    PubMed         Abstract available
    
    

    
    J Neurosurg

22. FANG S, Wang J, Zhang Z, Li Y, et al
    Brain network changes in patients with glioma-related epilepsy after frontal resection.
    J Neurosurg. 2026 Oct 9:1-12. doi: 10.3171/2026.4.JNS26314.
    PubMed         Abstract available
    
    
23. PRIETO R, Barrios L, Pascual JM
    Douglas W. C. Northfield (1902-1976): his crucial contribution to safer craniopharyngioma surgery.
    J Neurosurg. 2026 Oct 9:1-14. doi: 10.3171/2026.5.JNS26584.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

24. LIN G, Ding W, Chen Y, Xiong L, et al
    Gadolinium-free MR perfusion imaging based on generative adversarial network for primary intracranial tumor diagnosis: A multi-center study.
    Neuro Oncol. 2026;28:2500-2513.
    PubMed         Abstract available
    
    
25. ZHANG S, Singh O, Dazelle K, Quezado M, et al
    High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort.
    Neuro Oncol. 2026;28:2435-2448.
    PubMed         Abstract available
    
    
26. PETRY C, Boecke AS, Mohammed AO, Ghariwala NS, et al
    Spatially restricted iron-metabolism-associated stress programs prime invasive mesenchymal glioblastoma states in human tissue-context models.
    Neuro Oncol. 2026 Oct 8:noag220. doi: 10.1093.
    PubMed         Abstract available
    
    
27. HAN C, Wu J, Xie J, Li J, et al
    A MYCN-GAL-SREBP1 lipogenic axis drives proliferation in silent corticotroph adenomas.
    Neuro Oncol. 2026;28:2401-2416.
    PubMed         Abstract available
    
    
28. PINA Y, Umeh Garcia M, Boire A, Brenner A, et al
    Breaking barriers in leptomeningeal disease: A Society for Neuro-Oncology and The American Society of Clinical Oncology consensus review on clinical trial design and basic science integration.
    Neuro Oncol. 2026;28:2299-2312.
    PubMed         Abstract available
    
    
29. IPPAGUNTA SM, Arabzade A, Varadharajan S, Emanus E, et al
    Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma.
    Neuro Oncol. 2026;28:2472-2484.
    PubMed         Abstract available
    
    
30. UGOLINI A, Scirocchi F, De Leo A, Badii F, et al
    Targeting hypoxia-driven histone lactylation in myeloid cells synergizes with CD137 agonism to expand effector-like exhausted CD8+ T cells in glioblastoma.
    Neuro Oncol. 2026 Oct 8:noag226. doi: 10.1093.
    PubMed         Abstract available
    
    
31. BEAMISH J, de Fine Licht E, Bostrom P, Loden J, et al
    Socioeconomic status and longitudinal neurocognitive outcomes following childhood brain tumour diagnosis: a Swedish national population-based cohort study.
    Neuro Oncol. 2026 Oct 8:noag253. doi: 10.1093.
    PubMed         Abstract available
    
    
32. LIU J, Zhang Y, Yi X, Xie L, et al
    CEBPB integrates OSM signaling and eIF4G2-mediated alternative translation to configure enhancer landscape and sustain oncogenic CHI3L1 in glioblastoma.
    Neuro Oncol. 2026 Oct 8:noag246. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurology

33. WANG K, Smith JL, Vo AH, Sloan L, et al
    Neurology Journal Club: Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy.
    Neurology. 2026;107:e218666.
    PubMed         Abstract available
    
    

    
    Neuroradiology

34. MALLIO CA, Di Gennaro G, Ferrari U, Bernetti C, et al
    Perivascular spaces as MRI markers associated with radiation necrosis in brain metastases patients: an exploratory study.
    Neuroradiology. 2026 Oct 8. doi: 10.1007/s00234-026-04216.
    PubMed         Abstract available
    
    

    
    Neurosurgery

35. SHIH RM, Harary M, Bergsneider M, Wang M, et al
    Safety and Efficacy of Repeat Surgery for Recurrent Craniopharyngiomas: A RAPID Consortium Collaboration.
    Neurosurgery. 2026 Oct 8. doi: 10.1227/neu.0000000000004258.
    PubMed         Abstract available
    
    

    
    Radiol Artif Intell

36. NARAYAN A, Goh C, Mariajoseph F, Cui S, et al
    Comparative Performance of Federated and Centralized Learning for Brain Tumor Classification and Segmentation.
    Radiol Artif Intell. 2026 Oct 7:e260515. doi: 10.1148/ryai.260515.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum